Skip to main content

Stocks To Buy Today | Gland Pharma Share Price for Long term Investment 2022

Stocks To Buy Today | Gland Pharma Share Price

Gland Pharma Limited (NSE: GLAND) company’s core business segment is into Pharma and is been selected for investing long term horizon over an year and above based on the strong fundamental and technical analysis provided here in this article. Technical analysis indicators; Simple Moving Average (SMA) 200 below the SMA 300 while the Relative Strength Index (RSI) is showing at 36.66. The trend may continue to be little bit down trend followed by consolidation in near term which indicates a good stock accumulation period through stock SIP investment option in Zerodha Trading App for better stock price averaging while investing.


The market capitalization as on publishing day stands at Rs. 40334/- Crore positioning it in large cap stocks group listed on NSE India.

Gland Pharma Share Price

Gland Pharma Share Price is currently trading at Rs. 2473.35 per stock & Gland Pharma Technical Chart the performance of the stock over 2 years of time frame which is considered to be a good investment period shows decent profits & now the opportunities to invest based on above technical & following stock fundamentals. Similarly; Gland Pharma's 52 week low price at Rs. 2420/- & 52 week high price at 4350/-

Why one should consider Gland Pharma Share Price?

Following are the strong fundamental analysis of Gland Pharma Share Price will definitely make to think in one of the large cap companies of India for decent profits in a medium to long term investment horizon.

Fundamental Analysis of Gland Pharma

Market Capitalization Rs. 40334 Crore Return On Equity (ROE) 18.55%
P/E Ratio (TTM) 33.23 EPS (TTM) 73.72
P/B Ratio 5.62 Dividend Yield N/A
Industry P/E Ratio 33.94 Book Value 435.83
Debt to Equity 0 Face Value 1
Reference Groww app as on 20-07-2022 EOD.

Financial Statement of Gland Pharma

Yearly Revenue (Rs. Crores) Profit (Rs. Crores) Net Worth (Rs. Crores)
2018 1,623.0 321.0 2,410.0
2019 2,044.0 452.0 2,862.0
2020 2,633.0 773.0 3,646.0
2021 3,463.0 997.0 5,903.0
2022 4,401.0 1,212.0 7,158.0
Note: Data reference Groww app as on 20-07-2022 EOD.

Shareholding Pattern of Gland Pharma

Promoters 57.87%
Retail Investors 16.01%
Foreign Investors 9.41%
Mutual Funds 15.54%
Other Domestic Institutions 1.17%
Reference Groww app as on 20-07-2022 EOD.

Gland Pharma Limited

Gland Pharma is a pharmaceutical manufacturing company establish in 1978 for production of sterile injectables & active pharma ingradients (API) researched it its own R & D wing; now its having a capacity of 750 million units per annum with 7 facilities having 22 production lines for API formulations and 3 API units sterile injectables deivered in liquid injectables like vials, syringes, ampoules etc.,

The company produces world class quality API & sterile injectable products under cGMP compliances, regulatory norms & QMS quality standards with continual training in its facilities. The technological developments under progress to produce more complex molecules & injectables in niche segment for evolving in pan-India & global markets through global distribution and sales network, affiliation with healthcare institutions.

Company is progressing & breaking remarkable milestones with a mission to be a global leader in injectables with value-added total solutions by believing the team work culture, team spirit with customer in focus in mind & strong management policies. Read more about Gland Pharma Limited company here from its official website.

Competitors of Gland Pharma

As Gland Pharma comes under Pharma sector; there are quiet a few peer competitors to GLAND & here is a list of Top 5 Pharma Companies based on market capitalization as on publishing day are as follows…

  1. Gland Pharma
  2. Sun Pharma
  3. Divi's Lab
  4. Cipla
  5. Dr. Reddy's

How to invest in Stock Market with the Best Trading App in India?

Here is the list of top stock brokers in India who made the trading in stock market made hassle free and best user experience with very attractive competitive brokerage charges.

  • Zerodha
  • Groww
  • 5paisa

What makes the best to go for Zerodha Account Opening

Breaking the barriers of brokerage charges among other competitors by the time company incorporated in 2010; Evolve, rise & conquer the market with flat Rs.20/- or less; which ever is low concept, now Zerodha is on India's no.1 position.

Zerodha Kite Features

Why don't to utilize the Stock SIP investing option to invest in Gland Pharma on regular basis on convenient day of every month on Zerodha product Kite. Now Zerodha Account Opening is very easy and Zerodha Demat Account for starting stock SIP investing right now.

Do you know the stock broker who turned-up unicorn: Groww App

The tough competitor now to Zerodha is Groww who turned-up unicorn startup of India facilitating not only the stocks investing but also mutual funds unlike Zerodha only provides stock trading. Groww recently introduced US stocks trading into its new product offering. Why waiting for something else and start investing right now in Gland Pharma with Groww App.

Groww App Download

Excited; how to open demat account with Groww App; Here we share a link for opening the Demat account with Groww App.

Never forget the senior broker: 5paisa

Senior most broker among the above; 5paisa (a.k.a. IIFL Securities) using different accounts over a period of time; found 5paisa is now in line to the charges and best user experience with the app to consider. Click here to open Demat account with 5paisa App.


References and Links:

Happy investing for prosperity.
It take 30 long years to turn Rs. 1/- worth Rs. 1000/-, so start investing now.

Comments